Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: SDR-SI who wrote (1032)	6/12/1999 11:45:00 PM
From: Walkingshadow	Read Replies (2) \| Respond to of 1686

Steve--- Point well taken; most of what I know about BGEN's product pipeline comes from their website, and from boards elsewhere (which I found lacking; that's why I came here). So thank you for the links and the updates. I'll do some more homework, but I'm still on the fence about buying this one. But, I don't seen any reason to rush. I AM impressed with their balance sheet and fundamentals, but my only lurking doubt revolves around sustainability, which of course depends largely on the quality of their pipeline, as well as their competition----I'm a buy and hold type, you see... Incidentally, regarding Hirulog, I'm sure it will generate profits, but I'm not at all sure to what extent. There are very effective and widely used compteting products in the acute coronary syndrome arena, notably the (increasing) platelet glycoprotein GPIIb/IIa receptor antagonists; there are others being developed. The focus in cardiology in recent years has shifted from the hemostatic/fibrinolytic system to the platelet, which is central to the pathogenesis of acute coronary syndromes such as unstable angina and infarction. I wonder what the anticipated pricing of Hirulog will be compared to these agents..... I doubt that in most circumstances the agents would be used together. Most cardiologists right now use less heparin if they are also giving antiplatelet agents. Any thoughts? P.S. Maybe BGEN should hire you to update their website! :~) Thanks again, Walkingshadow